<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p103" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_103{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_103{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_103{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_103{left:341px;bottom:30px;}
#t5_103{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_103{left:377px;bottom:30px;}
#t7_103{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_103{left:540px;bottom:30px;}
#t9_103{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_103{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#tb_103{left:44px;bottom:63px;letter-spacing:0.1px;}
#tc_103{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_103{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_103{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_103{left:1106px;bottom:47px;letter-spacing:0.34px;}
#tg_103{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_103{left:36px;bottom:748px;letter-spacing:-0.13px;word-spacing:0.03px;}
#ti_103{left:36px;bottom:729px;letter-spacing:-0.09px;}
#tj_103{left:47px;bottom:711px;letter-spacing:-0.1px;word-spacing:0.01px;}
#tk_103{left:47px;bottom:693px;letter-spacing:-0.1px;}
#tl_103{left:47px;bottom:674px;letter-spacing:-0.09px;}
#tm_103{left:545px;bottom:682px;letter-spacing:-0.12px;}
#tn_103{left:569px;bottom:674px;letter-spacing:-0.09px;}
#to_103{left:47px;bottom:656px;letter-spacing:-0.09px;word-spacing:-0.03px;}
#tp_103{left:47px;bottom:638px;letter-spacing:-0.09px;}
#tq_103{left:47px;bottom:619px;letter-spacing:-0.09px;}
#tr_103{left:47px;bottom:601px;letter-spacing:-0.09px;}
#ts_103{left:368px;bottom:609px;letter-spacing:-0.12px;}
#tt_103{left:412px;bottom:601px;letter-spacing:-0.09px;}
#tu_103{left:47px;bottom:583px;letter-spacing:-0.1px;}
#tv_103{left:499px;bottom:590px;}
#tw_103{left:36px;bottom:564px;}
#tx_103{left:47px;bottom:564px;letter-spacing:-0.09px;}
#ty_103{left:47px;bottom:546px;letter-spacing:-0.1px;}
#tz_103{left:47px;bottom:528px;letter-spacing:-0.09px;}
#t10_103{left:47px;bottom:509px;letter-spacing:-0.09px;}
#t11_103{left:723px;bottom:517px;letter-spacing:-0.09px;}
#t12_103{left:746px;bottom:509px;letter-spacing:-0.09px;}
#t13_103{left:47px;bottom:491px;letter-spacing:-0.09px;}
#t14_103{left:47px;bottom:473px;letter-spacing:-0.1px;word-spacing:0.01px;}
#t15_103{left:47px;bottom:454px;letter-spacing:-0.1px;}
#t16_103{left:461px;bottom:462px;letter-spacing:-0.14px;}
#t17_103{left:1091px;bottom:95px;letter-spacing:-0.11px;}
#t18_103{left:492px;bottom:778px;letter-spacing:0.4px;word-spacing:-0.23px;}
#t19_103{left:35px;bottom:415px;letter-spacing:-0.1px;}
#t1a_103{left:35px;bottom:396px;letter-spacing:-0.09px;}
#t1b_103{left:35px;bottom:378px;letter-spacing:-0.1px;}
#t1c_103{left:35px;bottom:360px;letter-spacing:-0.09px;}
#t1d_103{left:35px;bottom:314px;letter-spacing:-0.1px;}
#t1e_103{left:35px;bottom:296px;letter-spacing:-0.09px;}
#t1f_103{left:35px;bottom:277px;letter-spacing:-0.09px;}
#t1g_103{left:35px;bottom:241px;letter-spacing:-0.11px;word-spacing:0.01px;}
#t1h_103{left:35px;bottom:222px;}
#t1i_103{left:46px;bottom:222px;letter-spacing:-0.1px;}
#t1j_103{left:41px;bottom:204px;}
#t1k_103{left:58px;bottom:204px;letter-spacing:-0.12px;word-spacing:0.02px;}
#t1l_103{left:41px;bottom:186px;}
#t1m_103{left:58px;bottom:186px;letter-spacing:-0.09px;}
#t1n_103{left:35px;bottom:167px;letter-spacing:-0.09px;}
#t1o_103{left:513px;bottom:167px;letter-spacing:-0.1px;}
#t1p_103{left:46px;bottom:149px;letter-spacing:-0.15px;word-spacing:0.06px;}
#t1q_103{left:167px;bottom:149px;}
#t1r_103{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_103{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_103{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_103{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_103{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_103{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_103{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_103{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.s7_103{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.s8_103{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s9_103{font-size:17px;font-family:Webdings_k6;color:#000;}
.sa_103{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts103" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg103Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg103" style="-webkit-user-select: none;"><object width="1210" height="935" data="103/103.svg" type="image/svg+xml" id="pdf103" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_103" class="t s0_103">NCCN Guidelines Version 4.2024 </span>
<span id="t2_103" class="t s0_103">Head and Neck Cancers </span>
<span id="t3_103" class="t s1_103">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_103" class="t s2_103">® </span>
<span id="t5_103" class="t s1_103">(NCCN </span>
<span id="t6_103" class="t s2_103">® </span>
<span id="t7_103" class="t s1_103">), All rights reserved. NCCN Guidelines </span>
<span id="t8_103" class="t s2_103">® </span>
<span id="t9_103" class="t s1_103">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_103" class="t s3_103">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="tb_103" class="t s3_103">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="tc_103" class="t s4_103">NCCN Guidelines Index </span>
<span id="td_103" class="t s4_103">Table of Contents </span>
<span id="te_103" class="t s4_103">Discussion </span>
<span id="tf_103" class="t s5_103">SURG-A </span>
<span id="tg_103" class="t s5_103">7 OF 8 </span>
<span id="th_103" class="t s5_103">Sentinel Lymph Node Biopsy </span>
<span id="ti_103" class="t s5_103">• SLN biopsy is an alternative to elective neck dissection for identifying occult cervical metastasis in patients with early (T1 or T2) oral </span>
<span id="tj_103" class="t s6_103">cavity carcinoma in centers where expertise for this procedure is available. Technical experience and judgment are required for successful </span>
<span id="tk_103" class="t s5_103">execution of lymphatic mapping and SLN. Its advantages include reduced morbidity and an improved cosmetic outcome. Rates of detection </span>
<span id="tl_103" class="t s5_103">of sentinel nodes in excess of 95% have been widely reported. </span>
<span id="tm_103" class="t s7_103">7-9 </span>
<span id="tn_103" class="t s5_103">Patients with metastatic disease in their sentinel nodes must undergo </span>
<span id="to_103" class="t s5_103">a completion neck dissection while those without may be observed. Accuracy of sentinel node biopsy for nodal staging of early oral </span>
<span id="tp_103" class="t s5_103">carcinoma has been tested extensively in multiple single-center studies and two multi-institutional trials against the reference standard </span>
<span id="tq_103" class="t s6_103">of immediately performed neck dissection or subsequent extended follow-up with a pooled estimate of sensitivity of 0.93 and negative </span>
<span id="tr_103" class="t s5_103">predictive values ranging from 0.88 to 1. </span>
<span id="ts_103" class="t s7_103">6,8-12 </span>
<span id="tt_103" class="t s5_103">While direct comparisons with the policy of elective neck dissection are lacking, available </span>
<span id="tu_103" class="t s5_103">evidence points towards comparable survival outcomes. </span>
<span id="tv_103" class="t s7_103">6 </span>
<span id="tw_103" class="t s5_103">• </span><span id="tx_103" class="t s6_103" data-mappings='[[108,"fi"]]'>Sentinel node biopsy is a technically demanding procedure. Procedural success rates for sentinel node identiﬁcation as well as accuracy </span>
<span id="ty_103" class="t s6_103" data-mappings='[[96,"ffi"]]'>of detecting occult lymphatic metastasis depend on technical expertise and experience. Hence, suﬃcient caution must be exercised when </span>
<span id="tz_103" class="t s6_103" data-mappings='[[1,"ff"],[96,"fl"]]'>oﬀering it as an alternative to elective neck dissection. This is particularly true in cases of ﬂoor-of-mouth cancer where accuracy of sentinel </span>
<span id="t10_103" class="t s5_103">node biopsy has been found to be lower than for other locations such as the tongue. </span>
<span id="t11_103" class="t s7_103">6,7 </span>
<span id="t12_103" class="t s5_103">Also, cancers of certain locations such as upper </span>
<span id="t13_103" class="t s5_103">gingiva and hard palate may not lend themselves well technically to this procedure. Likewise, occult cervical metastases are uncommon </span>
<span id="t14_103" class="t s6_103" data-mappings='[[71,"ff"]]'>in early lip cancer, but SLN biopsy has been shown to be feasible and eﬀective in patients with lip cancers deemed to be at high risk of </span>
<span id="t15_103" class="t s5_103">metastases generally based on tumor size or depth. </span>
<span id="t16_103" class="t s7_103">13 </span>
<span id="t17_103" class="t s8_103">Continued </span>
<span id="t18_103" class="t s5_103">PRINCIPLES OF SURGERY </span>
<span id="t19_103" class="t s5_103">Management of Recurrences </span>
<span id="t1a_103" class="t s5_103">Resectable primary cancers should be re-resected with curative intent if feasible, and recurrences in a previously treated neck should </span>
<span id="t1b_103" class="t s6_103" data-mappings='[[112,"fi"]]'>undergo surgery as well. Neck disease in an untreated neck should be addressed by formal neck dissection or modiﬁcation depending on the </span>
<span id="t1c_103" class="t s5_103">clinical situation. Non-surgical therapy may also be utilized as clinically appropriate. </span>
<span id="t1d_103" class="t s5_103">Surveillance </span>
<span id="t1e_103" class="t s5_103">All patients should have regular follow-up visits to assess for symptoms and possible tumor recurrence, health behaviors, nutrition, dental </span>
<span id="t1f_103" class="t s5_103">health, and speech and swallowing function. </span>
<span id="t1g_103" class="t s5_103">• Tumor evaluations must be performed by specialists skilled in head and neck clinical examination. </span>
<span id="t1h_103" class="t s5_103">• </span><span id="t1i_103" class="t s6_103">The frequency of evaluation is summarized elsewhere in the NCCN Guidelines for Head and Neck Cancers. </span>
<span id="t1j_103" class="t s9_103"></span><span id="t1k_103" class="t s8_103">Follow-up Recommendations (FOLL-A 1 of 2) </span>
<span id="t1l_103" class="t s9_103"></span><span id="t1m_103" class="t s8_103">Principles of Imaging (IMG-A) </span>
<span id="t1n_103" class="t s5_103">• For post systemic therapy/RT or RT neck evaluations, see </span><span id="t1o_103" class="t s8_103">Follow-up Recommendations: Post Systemic Therapy/RT or RT Neck Evaluation </span>
<span id="t1p_103" class="t s8_103">(FOLL-A 2 of 2)</span><span id="t1q_103" class="t s5_103">. </span>
<span id="t1r_103" class="t sa_103">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
